Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Am J Manag Care
    April 2024
  1. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
    Medication persistence and its impact on type 2 diabetes.
    Am J Manag Care. 2024;30:e124-e134.
    >> Share

    March 2024
  2. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
    Improving glycemic control in diabetes through virtual interdisciplinary rounds.
    Am J Manag Care. 2024;30:e78-e84.
    >> Share

  3. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
    Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
    Am J Manag Care. 2024;30:107-108.
    >> Share

  4. LAMONICA LC, Ren J, Jain N, Goldberg ES, et al
    At-home hemoglobin A1c testing during COVID-19 improved glycemic control.
    Am J Manag Care. 2024;30:e73-e77.
    >> Share

  5. LO JC, Chandra M, Yang W, Thompson N, et al
    Challenges of fracture risk assessment in Asian and Black women.
    Am J Manag Care. 2024;30:140-144.
    >> Share

    December 2023
  6. KERR D, Duncan I, Repetto E, Maroun R, et al
    Cost analysis of self-monitoring blood glucose in nonintensively managed type 2 diabetes.
    Am J Manag Care. 2023;29:670-675.
    >> Share

  7. LISS DT, Cherupally M, O'Brien MJ, Kang RH, et al
    Treatment modification after initiating second-line medication for type 2 diabetes.
    Am J Manag Care. 2023;29:661-668.
    >> Share

    November 2023
  8. HUGHES J, Sparkman A, Smith P, McCormack T, et al
    Charitable medication distribution improves care for uninsured patients with diabetes.
    Am J Manag Care. 2023;29:573-575.
    >> Share

    October 2023
  9. TRUONG B, Li Y, Zheng J, Qian J, et al
    Use of second-generation antidiabetic medication among a nationally representative sample.
    Am J Manag Care. 2023;29:e307-e316.
    >> Share

    September 2023
  10. RIGGS KR, Presley CA, Agne AA, Howell CR, et al
    Measuring continuity of care for diabetes: which visits to include?
    Am J Manag Care. 2023;29:e274-e279.
    >> Share

    August 2023
  11. YUN J, Filardo G, Ahuja V, Bowen ME, et al
    Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data.
    Am J Manag Care. 2023;29:e229-e234.
    >> Share

  12. STOECKER C, Nauman E, Bazzano AN, Price-Haywood EG, et al
    Non-face-to-face care management and service utilization in patients with diabetes.
    Am J Manag Care. 2023;29:417-422.
    >> Share

    June 2023
  13. ZAKERI M, Lewing BD, Contreras J, Sansgiry SS, et al
    Economic burden of nonadherence to standards of diabetes care.
    Am J Manag Care. 2023;29:e176-e183.
    >> Share

  14. COLVIN CL, Akinyelure OP, Rajan M, Safford MM, et al
    Diabetes, gaps in care coordination, and preventable adverse events.
    Am J Manag Care. 2023;29:e162-e168.
    >> Share

  15. TURK MT, Ritchie ND, Jakub K
    Stakeholder analysis: Medicare Diabetes Prevention Program awareness and implementation.
    Am J Manag Care. 2023;29:308-312.
    >> Share

  16. KAMAL KM
    The role of managed care professionals in the management of neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    >> Share

  17. ALMONY A
    Treatment approaches for neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    >> Share

  18. ALMONY A
    Disease burden of neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    >> Share

    April 2023
  19. MILLER-ROSALES C, Brewster AL, Shortell SM, Rodriguez HP, et al
    Multilevel influences on patient engagement and chronic care management.
    Am J Manag Care. 2023;29:196-202.
    >> Share

    February 2023
  20. LEWING BD, Wallick C, To TM, Masters H 3rd, et al
    Outcomes of antiviral treatment for influenza in type 2 diabetes.
    Am J Manag Care. 2023;29:e43-e50.
    >> Share

    January 2023
  21. RODRIGUEZ HP, Ciemins EL, Rubio K, Rattelman C, et al
    Health systems and telemedicine adoption for diabetes and hypertension care.
    Am J Manag Care. 2023;29:42-49.
    >> Share

    December 2022
  22. DATAR M, Ramakrishnan S, Chong J, Montgomery E, et al
    A kidney diagnostic's impact on physician decision-making in diabetic kidney disease.
    Am J Manag Care. 2022;28:654-661.
    >> Share

  23. KYRILLOS J
    Semaglutide 2.4-mg injection as a novel approach for chronic weight management.
    Am J Manag Care. 2022;28.
    >> Share

  24. MASSIE DC, Amaro A, Kaplan M
    Patient well-being and the clinical and economic burdens associated with obesity in the United States.
    Am J Manag Care. 2022;28.
    >> Share

    November 2022
  25. OLOMU A, Tikaria R, Kelly-Blake K, Hart-Davidson W, et al
    Type 2 diabetes patient activation and mHealth interventions decreased cardiovascular disease risk.
    Am J Manag Care. 2022;28:e392-e398.
    >> Share

  26. RAMACHANDRAN S, Zhang Y, Dunn TJ, Goswami S, et al
    Impact of food affordability on diabetes-related preventable hospitalization.
    Am J Manag Care. 2022;28:574-580.
    >> Share

    October 2022
  27. KARPES MATUSEVICH AR, Xavier C, Rasu RS
    Long-term medication adherence and preventive vs reactive care utilization among older adults with diabetes.
    Am J Manag Care. 2022;28:e378-e387.
    >> Share

  28. BAXTER SL, Quackenbush Q, Cerda J, Gregg C, et al
    Implementing clinical informatics tools for primary care-based diabetic retinopathy screening.
    Am J Manag Care. 2022;28:e355-e362.
    >> Share

    September 2022
  29. SHAWAHNA R, Thawabi F, Salah R, Ramadan S, et al
    Pharmaceutical care services for patients with diabetes: a systematic scoping review.
    Am J Manag Care. 2022;28:e339-e346.
    >> Share

  30. BELLIGUND P, Attaway A, Lopez R, Damania D, et al
    Diabetes associated with higher health care utilization and poor outcomes after COPD-related hospitalizations.
    Am J Manag Care. 2022;28:e325-e332.
    >> Share

    August 2022
  31. IYER NN, Shah S, Ganz ML, Dang-Tan T, et al
    Glucose-lowering treatment patterns in patients with diabetic kidney disease.
    Am J Manag Care. 2022;28:e301-e307.
    >> Share

  32. BETTS KA, Song J, Elliott J, Warnock N, et al
    Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2022;28.
    >> Share

  33. POCHOPIEN M, Cherney DZI, Drzewiecka A, Folkerts K, et al
    Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2022;28.
    >> Share

  34. COOK DJ, Cohen K, Deypalan MN
    A data-based foundation for managing hypertension services.
    Am J Manag Care. 2022;28:e282-e288.
    >> Share

  35. NAIR R, Meadows E, Sheer R, Lipkovich I, et al
    Activation, physical activity, and outcomes among individuals with T2D.
    Am J Manag Care. 2022;28:374-380.
    >> Share

    July 2022
  36. MCADAM-MARX C
    Addressing healthcare disparities and managed care considerations with continuous glucose monitoring.
    Am J Manag Care. 2022;28.
    >> Share

  37. GOLDMAN J
    Continuous glucose monitoring metrics: interpretation and integrations.
    Am J Manag Care. 2022;28.
    >> Share

  38. UNGER J
    Continuous glucose monitoring overview: features and evidence.
    Am J Manag Care. 2022;28.
    >> Share

    March 2022
  39. KIM JE
    Exploring neovascular age-related macular degeneration and diabetic macular edema and advances in treatment.
    Am J Manag Care. 2022;28.
    >> Share

  40. LIU Y
    Managed care opportunities and approaches to select treatment for sight preservation.
    Am J Manag Care. 2022;28.
    >> Share

  41. SOLBERG LI, Carlin CS, Peterson KA, Eder M, et al
    Diabetes care quality: do large medical groups perform better?
    Am J Manag Care. 2022;28:101-107.
    >> Share

    December 2021
  42. POCHOPIEN MT, Cherney DZI, Folkerts K, Levy P, et al
    FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    >> Share

  43. BETTS KA, Song J, Faust E, Yang K, et al
    Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    >> Share

  44. FRIED LF, Petruski-Ivleva N, Folkerts K, Schmedt N, et al
    ACE inhibitor or ARB treatment among patients with diabetes and chronic kidney disease.
    Am J Manag Care. 2021;27.
    >> Share

    November 2021
  45. GRUSS I, Firemark A, Papajorgji-Taylor D, Fitzpatrick SL, et al
    Challenges with implementing the Diabetes Prevention Program for Medicare beneficiaries in an integrated health system.
    Am J Manag Care. 2021;27:e400-e403.
    >> Share

  46. MILLER E, Kerr MSD, Roberts GJ, Nabutovsky Y, et al
    Flash CGM associated with event reduction in nonintensive diabetes therapy.
    Am J Manag Care. 2021;27:e372-e377.
    >> Share

    October 2021
  47. ZUPA MF, Piette JD, Stoll SC, Obrosky DS, et al
    Patient and supporter factors affecting engagement with diabetes telehealth.
    Am J Manag Care. 2021;27:409-414.
    >> Share

  48. PANDYA N, Trenery A, Sieradzan R, Gabai C, et al
    Hypoglycemia upon hospital admission from long-term care: health care resource use.
    Am J Manag Care. 2021;27:e349-e354.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016